Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Diffuse Intrinsic Pontine Glioma × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 100 Breast Neoplasms 70 Colorectal Neoplasms 46 Stomach Neoplasms 39 Lung Neoplasms 38 Rectal Neoplasms 36 Pancreatic Neoplasms 34 Neoplasm Metastasis 30 Esophageal Squamous Cell Carcinoma 30 Neoplasms 26 Esophageal Neoplasms 25 Head and Neck Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 20 Ovarian Neoplasms 20 Triple Negative Breast Neoplasms 18 Nasopharyngeal Carcinoma 18 Colonic Neoplasms 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Small Cell Lung Carcinoma 14 Leukemia, Myeloid, Acute 14 Recurrence 13 Uterine Cervical Neoplasms 12 Glioblastoma 12 Prostatic Neoplasms 11 Carcinoma, Squamous Cell 11 Brain Neoplasms 11 Sarcoma 10 Lymphoma 10 Fallopian Tube Neoplasms 9 NSCLC 8

Interventions

Temozolomide 10 Radiotherapy 9 Bevacizumab 6 Everolimus 4 ribociclib 3 Radiation 3 Dasatinib 3 Valproic Acid 2 TIC10 compound 2 Re-Irradiation 2 Panobinostat 2 Nivolumab 2 Mebendazole 2 Irinotecan 2 GDC-0084 2 Etoposide 2 Erlotinib Hydrochloride 2 Diphtheria-Tetanus Vaccine 2 Cyclophosphamide 2 Cilengitide 2 Cetuximab 2 vandetanib 1 tovorafenib 1 temsirolimus 1 spartalizumab 1 sargramostim 1 reolysin 1 pembrolizumab 1 ovex 1 nimotuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03620032 2023-12-06

DIPG

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡